Synonyms: | |
Status: | Phase 2 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | 23IQ3PO968 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Monocyte differentiation antigen CD14 inhibitor | PubMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Respiratory Distress Syndrome | 2 | D012128 | ClinicalTrials |
Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
Dengue | 2 | D003715 | ClinicalTrials |
Respiratory Distress Syndrome | 2 | D012128 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL2109330 |
FDA SRS | 23IQ3PO968 |